Raymond “Ray” Blanchard, Ph.D.
Entrepreneur in Residence
Dr. Ray Blanchard joins BHI's EIR team with over two decades of experience in the life sciences tools industry. With a strong technical background in genomics, both in business and academic settings, and more than a decade of expertise in technology scouting and negotiating IP licensing in the life sciences sector, Ray has honed his skills as an adept navigator of business complexities in the diagnostics and research tools industries.
Prior to becoming an EIR at BHI, Ray held the position of Director of Corporate Business Development at QIAGEN. In this role, he provided licensing and alliance management support to molecular diagnostics, life sciences, and bioinformatics product teams globally. During his tenure at QIAGEN, Ray began collaborating with BHI and represented QIAGEN on its board from 2022 to 2024.
Ray's business endeavors have focused on clinical, applied, and basic research genomics for oncology companion diagnostics, infectious disease/syndromic testing, as well as somatic mutation and gene expression pathway analysis/interpretation of large datasets. In the diagnostics field, his work has spanned a diverse range of testing methods, from IVD kits to Laboratory Developed Tests (LDT) and near-patient/point-of-care testing.
Before transitioning to corporate business development, Ray began his industry career as a product development scientist and R&D project manager at SuperArray/SABiosciences, a Maryland startup known for its pathway-focused real-time PCR arrays, which was later acquired by QIAGEN.
Ray's academic journey began at the University of California, Riverside, where he earned a PhD in biochemistry/molecular biology. His postdoctoral training in the Food Science & Human Nutrition Department at the University of Florida led to a faculty research position and the co-founding of the department's Nutritional Genomics Laboratory with Dr. Robert J. Cousins. Ray has authored numerous articles and book chapters on topics including nutritional regulation of gene expression, novel gene/biomarker discovery, and mammalian zinc physiology.